The GIFT Nifty futures, which are an early indicator of the Nifty50 index stocks, were trading lower by 59 points at 26,001, indicating that the domestic benchmark indices are likely to make a negative start on Tuesday. 

Earlier on Monday, 17 November, the Domestic benchmark indices S&P BSE Sensex surged by 388 points or 0.46%, and settled at 84,950, while the Nifty50 traded 0.40% higher or 103 points, closing at 26,103.

Here are some stocks that are likely to remain in focus on 18 November.

JSW Infrastructure: JSW Infrastructure, through its subsidiary JSW Overseas FZE, will acquire a 51% stake in South Minerals Port Company SAOC, a new port SPV in Oman. The deal, finalised on 17 November, will make the Omani entity a step-down subsidiary once the transaction closes.

HCL Technologies: HCLTech, in partnership with Nvidia, has launched a new innovation lab in Santa Clara, California. The lab focuses on physical AI and cognitive robotics, integrating Nvidia’s technology stack with HCLTech’s AI capabilities. It is connected to HCLTech’s global AI Lab network to support companies in building and scaling AI solutions.

Pace Digitek: Pace Digitek announced a Rs 929.76-crore order from Maharashtra State Power Generation Company Limited (MSPGCL) for a 200 MWAC ground-mounted solar PV power plant. The project includes design, engineering, supply, installation, testing, and three years of operations and maintenance, along with power evacuation to the state transmission substation.

Tata Power Renewable Energy: Tata Power Renewable Energy has completed a 300 MW solar project in Bikaner, Rajasthan, using DCR-compliant bifacial modules and about 7.75 lakh panels. Built over two and a half years, the project will supply its entire output to Punjab State Power Corporation Ltd and is expected to generate around 17,230 million units of green energy over its lifetime.

Saatvik Green Energy: Saatvik Solar Industries, a subsidiary of Saatvik Green Energy, secured new domestic orders worth Rs 177.50 crore for solar PV modules from a leading IPP/EPC player. Classified as repeat business, the order will be executed between November and December 2025. The company has not disclosed additional terms beyond module supply.

AstraZeneca Pharma: The company, along with Sun Pharmaceutical Industries, signed their second brand partnership for Sodium Zirconium Cyclosilicate (SZC). The collaboration aims to expand the availability of SZC for treating Hyperkalaemia in India, with both companies promoting, marketing, and distributing the drug under separate brands.

Marksans Pharma: Marksans Pharma’s UK subsidiary, Relonchem, received MHRA approval to market Mefenamic Acid Film-Coated Tablets in 250 mg and 500 mg strengths. The drug is used for short-term relief of mild to moderate pain, including menstrual discomfort.

WPIL: WPIL’s South African subsidiary secured an 821-million-Rand (Rs 426 crore) contract from METSI KE MATLA JV to execute complete electromechanical and instrumentation works for the MCWAP2 project of the Trans Caledon Tunnel Authority. The company plans to commission the project within 48 months.

The future of investing is here!
Unicorn Signals leverages advanced AI technology to provide you with powerful market predictions and actionable stock scans. Download the app todayand 10x your trading & investing journey!